The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS). Classes of medications include α1-adrenoceptor blockers, 5α-reductase inhibitors, and phosphodiesterase 5 inhibitors....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Androl Urol
Autori principali: Gandhi, Jason, Weissbart, Steven J., Smith, Noel L., Kaplan, Steven A., Dagur, Gautam, Zumbo, Anna, Joshi, Gargi, Khan, Sardar Ali
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2017
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422692/
https://ncbi.nlm.nih.gov/pubmed/28540239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.03.57
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi